Correction: Real-life use of talimogene laherparepvec (T-VEC) in melanoma patients in centers in Austria, Switzerland and Germany
Enregistré dans:
| Format: | article |
|---|---|
| Langue: | EN |
| Publié: |
BMJ Publishing Group
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/98b49330b88e4cb3a30a40500467de37 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
| id |
oai:doaj.org-article:98b49330b88e4cb3a30a40500467de37 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:98b49330b88e4cb3a30a40500467de372021-11-27T05:30:07ZCorrection: Real-life use of talimogene laherparepvec (T-VEC) in melanoma patients in centers in Austria, Switzerland and Germany10.1136/jitc-2020-001701corr12051-1426https://doaj.org/article/98b49330b88e4cb3a30a40500467de372021-10-01T00:00:00Zhttps://jitc.bmj.com/content/9/10/e001701corr1.fullhttps://doaj.org/toc/2051-1426BMJ Publishing GrouparticleNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENJournal for ImmunoTherapy of Cancer, Vol 9, Iss 10 (2021) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 |
| spellingShingle |
Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Correction: Real-life use of talimogene laherparepvec (T-VEC) in melanoma patients in centers in Austria, Switzerland and Germany |
| format |
article |
| title |
Correction: Real-life use of talimogene laherparepvec (T-VEC) in melanoma patients in centers in Austria, Switzerland and Germany |
| title_short |
Correction: Real-life use of talimogene laherparepvec (T-VEC) in melanoma patients in centers in Austria, Switzerland and Germany |
| title_full |
Correction: Real-life use of talimogene laherparepvec (T-VEC) in melanoma patients in centers in Austria, Switzerland and Germany |
| title_fullStr |
Correction: Real-life use of talimogene laherparepvec (T-VEC) in melanoma patients in centers in Austria, Switzerland and Germany |
| title_full_unstemmed |
Correction: Real-life use of talimogene laherparepvec (T-VEC) in melanoma patients in centers in Austria, Switzerland and Germany |
| title_sort |
correction: real-life use of talimogene laherparepvec (t-vec) in melanoma patients in centers in austria, switzerland and germany |
| publisher |
BMJ Publishing Group |
| publishDate |
2021 |
| url |
https://doaj.org/article/98b49330b88e4cb3a30a40500467de37 |
| _version_ |
1718409178739900416 |